| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/15/2007 | US20070059806 Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection |
| 03/15/2007 | US20070059803 Mammalian cytokines; related reagents and methods |
| 03/15/2007 | US20070059762 Insulin resistance curative and method of screening the same |
| 03/15/2007 | US20070059709 Staphylococcus aureus antibacterial target genes |
| 03/15/2007 | US20070059689 Hybrid glycosylated products and their production and use |
| 03/15/2007 | US20070059684 Method of identifying an antiviral agent |
| 03/15/2007 | US20070059393 Composition for inhibition or prevention of bone density |
| 03/15/2007 | US20070059392 COX inhibitor |
| 03/15/2007 | US20070059390 Compositions for inhibiting or reducing inflammation of skin |
| 03/15/2007 | US20070059389 Preventives or remedies for infection, anti-endotoxin agents, vaccine adjuvants and growth promoters |
| 03/15/2007 | US20070059388 Pharmaceutical composition containing a safe extracts of plants for the treating and preventing of diabetes and cardiovascular disease |
| 03/15/2007 | US20070059387 Use of a polyphenol for the treatment of a cancerous or precancerous lesion of the skin |
| 03/15/2007 | US20070059385 Safe pharmaceutical composition for treating and preventing cancer and method of use |
| 03/15/2007 | US20070059383 Therapeutic composition and method of supporting the immune system |
| 03/15/2007 | US20070059381 Treatment of amd with combination of ingredients |
| 03/15/2007 | US20070059378 Medical composition for balancing bodily processes |
| 03/15/2007 | US20070059377 Compositions and methods for the treatment of wounds and the reduction of scar formation |
| 03/15/2007 | US20070059371 Nanoparticulate ebastine formulations |
| 03/15/2007 | US20070059369 Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders |
| 03/15/2007 | US20070059367 Drug Delivery System and Associated Methods |
| 03/15/2007 | US20070059366 1-(8-{4-[3-(5-Fluoro-1H-indol-3-yl)-propyl]-piperazin-1-yl}-2-methyl-4H-benzo[1,4]oxazin-3-one (SLV 314); coated tablet comprising compressed comprises hypromellose, microcrystalline cellulose, and lubricant; G protein coupled receptor inhibitors; solubility, stability and ease of formulation |
| 03/15/2007 | US20070059365 Novel formulation of ropinirole |
| 03/15/2007 | US20070059364 Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinity |
| 03/15/2007 | US20070059361 Fast-disintegrating epinephrine tablets for buccal or sublingual administration |
| 03/15/2007 | US20070059360 Water-dispersible anti-retroviral pharmaceutical compositions |
| 03/15/2007 | US20070059359 Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof |
| 03/15/2007 | US20070059357 Adiponectin production enhancer |
| 03/15/2007 | US20070059356 Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| 03/15/2007 | US20070059354 Sustained release dosage forms of oxcarbazepine |
| 03/15/2007 | US20070059352 Therapeutic liposomes |
| 03/15/2007 | US20070059351 Transdermal patches containing a nitric oxide-donor and a second active agent and associated methods |
| 03/15/2007 | US20070059350 Agents for controlling biological fluids and methods of use thereof |
| 03/15/2007 | US20070059349 Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
| 03/15/2007 | US20070059346 Film comprising therapeutic agents |
| 03/15/2007 | US20070059344 Use of a High-Oleic and High-Tocol Diet in Combination With a Non-Tocol Antioxidant for Improving Animal Meat Quality |
| 03/15/2007 | US20070059342 Method and palatable pharmaceutical composition for treating herpes in animals |
| 03/15/2007 | US20070059341 Physiologically active agents containing vicinal dithioglycols and use thereof in various branches of economy |
| 03/15/2007 | US20070059340 Omega-3 Fatty Acids Encapsulated In Zein Coatings and Food Products Incorporating the Same |
| 03/15/2007 | US20070059339 Nutraceutical; aqueous extract of Sibiraea leaves; obesity, lipid metabolism, hypoglycemic agent, hair growth, healthy food |
| 03/15/2007 | US20070059338 Compositions and techniques for localized therapy |
| 03/15/2007 | US20070059337 Cyclic acetal biomaterials |
| 03/15/2007 | US20070059334 Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles |
| 03/15/2007 | US20070059321 Methods of reducing minimal inhibitory concentration of antibiotics and compositions resulting therefrom |
| 03/15/2007 | US20070059319 Methods of screening for immuno-adjuvants and vaccines comprising anti-microtubule immuno-adjuvants |
| 03/15/2007 | US20070059317 Potent immunostimulants from microalgae |
| 03/15/2007 | US20070059316 Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted pdt agents |
| 03/15/2007 | US20070059310 Therapeutic combination compositions and methods of using same |
| 03/15/2007 | US20070059308 efficient, high throughput screening of antibody libraries against proteins targets; for screening a diverse antibody library for antibodies that bind to a membrane protein such as a chemokine receptor in yeast |
| 03/15/2007 | US20070059307 Biological products |
| 03/15/2007 | US20070059303 monoclonal antibody for prevention and treatment of allergies, asthma, crohn's and lymes disease, arthritis, diabetes, glomerularnephritis, vision defects, skin disorders, sarcoidosis and viral diseases |
| 03/15/2007 | US20070059299 S-adenosyl methionine decarboxylase inhibition for the treatment of a herpes simplex virus infection |
| 03/15/2007 | US20070059298 Method for administering a vaginal care composition |
| 03/15/2007 | US20070059297 Methods and compositions for improving visual acuity |
| 03/15/2007 | US20070059296 Probiotic composition having acid-resistant enteric coating |
| 03/15/2007 | US20070059278 Anhydrous composition containing an acid-acid buffer system |
| 03/15/2007 | US20070059277 Sachet formulation for amine polymers |
| 03/15/2007 | US20070059276 Bi-modal hyaluronate |
| 03/15/2007 | US20070059274 Ophthalmic compositions containing a PVA/borate gelling system |
| 03/15/2007 | US20070059272 Modulation of microbial pathogen-host cell interactions |
| 03/15/2007 | US20070059271 polyethylene glycol/poly( beta -benzyl-L-aspartate)-ac block copolymer; useful as carrier for in vivo delivery of active substances such as DNA; enables provision of PIC micelles having higher gene transfer effectivity |
| 03/15/2007 | US20070059270 Ion exchange resin treated to control swelling |
| 03/15/2007 | US20070059265 Benzylidene-1,3-thiazolidine-2,4-dione compounds for stimulating or inducing the growth and/or for reducing the loss and/or for increasing the density of keratin fibers |
| 03/15/2007 | US20070059261 Antimycotic nail polish formulations comprising substituted 2-aminothiazoles as an active substance |
| 03/15/2007 | US20070059259 Compositions and methods for mitigating skin irritation |
| 03/15/2007 | US20070059255 Preventing or treating viral, bacterial, fungal and yeast infections and cancer by administering an aqueous mixture including a peroxygen compound (peracid and peroxide) and a transition metal or alloy; may also include an alcohol |
| 03/15/2007 | US20070059254 Compositions for delivering 5-ht agonists across the oral mucosa and methods of use thereof |
| 03/15/2007 | US20070059251 applying a hydrophilic foam ( isophoron diisocyanate end capped polyoxyethylene glycol) substrate and a polymeric hydrophilic agent ( starach grafted copolymer of acrylic acid-acylamide sodium salt) to a portion of the surface of bruised skin reduce the severity of bruising (result of surgery, injury) |
| 03/15/2007 | US20070059249 Acute treatment of social phobia |
| 03/15/2007 | US20070059245 Protein cages for the delivery of medical imaging and therapeutic agents |
| 03/15/2007 | US20070059244 Optical imaging of rheumatoid arthritis |
| 03/15/2007 | US20070059243 Method of treating or inhibiting the development of brain inflammation and sepsis |
| 03/15/2007 | US20070059242 Methods to identify therapeutic agents |
| 03/15/2007 | US20070059241 neutralizing monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1); anticancer agent |
| 03/15/2007 | DE202007000338U1 Zusammensetzung zur Vorbeugung und Behandlung von Gefäßverschlusserkrankungen Composition for the prevention and treatment of vascular occlusive diseases |
| 03/15/2007 | DE202006016229U1 Injektionsvorrichtung mit Lokalanästhetikum zur Soforttherapie von Insektenstichen für jedermann With local anesthetic injection device for immediate treatment of insect bites for everyone |
| 03/15/2007 | DE112005000909T5 Hypoallergene Metallaminosäure-Chelate und Zusammensetzung, die Metallaminosäure-Chelate enthalten Containing hypoallergenic metal amino acid chelates and composition of the metal amino acid chelates |
| 03/15/2007 | DE102005042583A1 Iminooxazolidin-Derivate und ihre Verwendung Iminooxazolidin derivatives and their use |
| 03/15/2007 | DE102005017605B4 Substituierte 2-Aminoalkylthio-benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted 2-aminoalkylthio-benzimidazoles, process for their preparation and their use as medicaments |
| 03/15/2007 | DE102004002885B4 Neue medizinisch einsetzbare Pyrrolalkaloide: Verfahren zu ihrer Isolierung, Synthese, sie enthaltende Arzneimittel und deren Verwendung New medical usable pyrrole alkaloids: methods for their isolation, synthesis, pharmaceutical compositions containing them and their use |
| 03/15/2007 | CA2820510A1 Treatment of autoimmune diseases |
| 03/15/2007 | CA2641386A1 Endothelin receptors in morphine withdrawal |
| 03/15/2007 | CA2622079A1 Amide and carbamate derivatives of alkyl substituted n-[4-(4-amino-1h-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamides and methods |
| 03/15/2007 | CA2622076A1 Bicyclic derivatives as modulators of voltage gated ion channels |
| 03/15/2007 | CA2621988A1 Quinoline derivatives and use as antitumor agents |
| 03/15/2007 | CA2621973A1 Chimeric hcn channels |
| 03/15/2007 | CA2621964A1 Antisense antiviral compound and method for treating picornavirus infection |
| 03/15/2007 | CA2621879A1 Benzimidazole thiophene compounds as plk inhibitors |
| 03/15/2007 | CA2621841A1 Tetracyclic indole derivatives as antiviral agents |
| 03/15/2007 | CA2621836A1 Isoquinolines as igf-1r inhibitors |
| 03/15/2007 | CA2621820A1 Isoquinolines derivatives as igf-1r inhibitors |
| 03/15/2007 | CA2621774A1 A medical composition for treating wounds |
| 03/15/2007 | CA2621767A1 Prion-specific peptoid reagents |
| 03/15/2007 | CA2621582A1 Prevention of hypotension and stabilization of blood pressure in hemodialysis patients |
| 03/15/2007 | CA2621577A1 Methods and compositions for oral administration of proteins |
| 03/15/2007 | CA2621564A1 Pyridine derivatives and their use in the treatment of psychotic disorders |
| 03/15/2007 | CA2621560A1 Modulation of neurogenesis by hdac inhibition |
| 03/15/2007 | CA2621545A1 Ramipril formulation |
| 03/15/2007 | CA2621503A1 Triazole derivatives useful as axl inhibitors |
| 03/15/2007 | CA2621486A1 Acute treatment of social phobia |
| 03/15/2007 | CA2621474A1 1,3-disubstituted indole derivatives for use as ppar modulators |